Wells Fargo & Company Sarepta Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 111,367 shares of SRPT stock, worth $14.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,367

Previous 107,570 3.53%

Holding current value

$14.5 Million

Previous $17 Million 18.16%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$124.33 - $156.75 $472,081 - $595,179	3,797 Added 3.53%	111,367 $13.9 Million
Q2 2024 Aug 13, 2024	SELL	$113.33 - $163.85 $1.35 Million - $1.95 Million	-11,906 Reduced 9.97%	107,570 $17 Million
Q1 2024 May 10, 2024	SELL	$93.7 - $141.53 $441,982 - $667,597	-4,717 Reduced 3.8%	119,476 $15.5 Million
Q4 2023 Feb 09, 2024	SELL	$67.31 - $124.76 $4.41 Million - $8.17 Million	-65,464 Reduced 34.52%	124,193 $12 Million
Q3 2023 Nov 13, 2023	SELL	$102.5 - $123.59 $155,082 - $186,991	-1,513 Reduced 0.79%	189,657 $23 Million
Q2 2023 Aug 15, 2023	BUY	$106.4 - $157.19 $5.97 Million - $8.82 Million	56,133 Added 41.57%	191,170 $21.9 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $2.21 Million - $2.93 Million	18,775 Added 16.15%	135,037 $18.6 Million
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $128,293 - $168,069	1,272 Added 1.11%	116,262 $15.1 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $1.88 Million - $2.96 Million	24,784 Added 27.47%	114,990 $12.7 Million
Q2 2022 Aug 12, 2022	SELL	$62.69 - $88.44 $1.75 Million - $2.47 Million	-27,875 Reduced 23.61%	90,206 $6.76 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $3.18 Million - $4.55 Million	50,361 Added 74.37%	118,081 $9.22 Million
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $1.92 Million - $2.47 Million	-24,873 Reduced 26.86%	67,720 $6.1 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $972,199 - $1.36 Million	14,737 Added 18.93%	92,593 $8.56 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $1.18 Million - $1.48 Million	-17,024 Reduced 17.94%	77,856 $6.05 Million
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $41 Million - $96 Million	-567,948 Reduced 85.69%	94,880 $7.07 Million
Q4 2020 Feb 09, 2021	BUY	$125.56 - $178.74 $9.6 Million - $13.7 Million	76,438 Added 13.04%	662,828 $113 Million
Q3 2020 Nov 05, 2020	BUY	$127.12 - $172.34 $4.49 Million - $6.09 Million	35,348 Added 6.41%	586,390 $82.3 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $5.95 Million - $11 Million	63,985 Added 13.14%	551,042 $88.4 Million
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $40.1 Million - $64.1 Million	487,057 New	487,057 $47.6 Million

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Sarepta Therapeutics, Inc. Transaction History